已收盤 10-08 16:00:00 美东时间
0.000
0.00%
政策赋能+管线扩容 近日,诺泰生物分别收到了国家药品监督管理局签发的注射用醋酸西曲瑞克药品注册证书、阿戈美拉汀片药品注册证书。 注射用醋酸西曲瑞克(生殖领域)与...
07-31 16:43
Artelo gets Buy rating from Boral Capital after positive updates on ART27.13, ART26.12, and preclinical success of its candidate for depression.
07-09 03:06
Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological or neurological
07-07 19:46
Aytu enters the over $22 billion United States prescription major depressive disorder ("MDD") market with the first-in-class oral selective serotonin 5HT1a receptor agonist for adults with MDD.EXXUA has demonstrated
06-06 20:07
Hims & Hers Health最近全现金收购Zava,使其成为泛欧洲运营商,增加了可触达的人口数量。有外国分析师认为,收购Zava使其估值由昂贵变...
06-05 21:14
近日,诺泰生物分别收到了国家药品监督管理局签发的马来酸氟伏沙明片药品注册证书、舒林酸上市批准通知书。马来酸氟伏沙明片属于《国家基本医疗保险、工伤保险和生育保险药...
05-28 08:37
ABVC BioPharma, Inc. (NASDAQ:ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system (CNS), ophthalmology, and oncology/hematology indications, today announced
05-09 23:05
摘要:对于工业生产重组蛋白生物制药,中国仓鼠卵巢(CHO)细胞因其能够生产具有人类样翻译后修饰的高质量生物制剂而成为最广泛采用的宿主细胞系统。与随机整合不同,基...
2024-11-09 10:37